Healthcare diagnostics company Labcorp Holdings (NYSE:LH) in Q4 CY2025, but sales rose 5.6% year on year to $3.52 billion. On the other hand, the company’s outlook for the full year was close to ...

The company reported revenue of $3.52 billion, up from $3.33 billion in Q4 2024 but below the Wall Street consensus estimate of $3.56 billion.

Labcorp (NYSE:LH) executives said the company delivered what CEO Adam Schechter called a “very strong year” in 2025, citing ...

Labcorp (LH) stock dips as the company posts mixed Q4 2025 financials, falling short of Street forecasts for revenue while ...

Labcorp Holdings Inc. (NYSE:LH) delivered fourth-quarter adjusted earnings above expectations on Tuesday, though revenue came in marginally below Wall Street estimates as the diagnostics group closed ...

Healthcare diagnostics company Labcorp Holdings (NYSE:LH) fell short of the market’s revenue expectations in Q4 CY2025, but ...

"In 2025, Labcorp grew revenue over 7% and delivered double-digit adjusted EPS growth, margin expansion and strong free cash flow. Performance was driven by continued strength in our Diagnostics and ...

The addition of Scott to the Fortrea team while Oren becomes fully dedicated to the medical and scientific aspects of development is a win for clients,” said Anshul Thakral, CEO. “Working closely with ...

Laboratory services provider Labcorp forecast annual profit above Wall Street estimates on Tuesday, banking on robust demand ...

Labcorp expects full-year earnings in the range of $17.55 to $18.25 per share, with revenue in the range of $14.61 billion to ...

The company struck three deals in New York last year as part of its push to acquire hospital and regional testing labs.

Labcorp continues its Northeast push through a multi-year partnership with SOMOS, one of New York's largest independent ...